ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AMRN Amarin Corp

92.50
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Amarin Corp LSE:AMRN London Ordinary Share GB00B29VL935 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 92.50 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Amarin Share Discussion Threads

Showing 51 to 74 of 225 messages
Chat Pages: 9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
24/4/2007
16:15
so far its just MMS marking it down - not many sells at all

but will wait for delayed trades before conclusions are made.

MM

money mad
24/4/2007
16:14
if anyone is still interested,take five minutes and look over there web site. find out for yourself,dyor etc etc. p.s. i do hold these shares.
mr mat
24/4/2007
16:13
jarvisd why?
money mad
24/4/2007
16:12
Just tripled my holding.....seems very oversold.

P

patricktrfc
24/4/2007
16:12
zzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzz!
should/will fall further on wed.

jarvisd4e
24/4/2007
16:10
anyone else any views or am i here alone
money mad
24/4/2007
16:05
and all the director buying i forgot to mention - must have more up there sleeve
money mad
24/4/2007
16:02
How big was huntingdons disease for this treatment - Miraxion is not just in trial for Huntingdons disease - but for other CNS disorders

Amarin's core development pipeline includes Miraxion for CNS disorders, an oral
formulation of apomorphine for treating patients with advanced Parkinson's
disease, a nasal formulation of lorazepam for treating emergency seizures and
our proprietary pre-clinical combinatorial lipid program.

Seems oversold - well not that there seems to be many visible sellers

MM

money mad
24/4/2007
15:49
Will be no serious buying until it's more stable, Winterflood et al don't appear know what to do with the share price this afternoon.

Q

quidzinn
24/4/2007
15:49
L2 1v2 for anyone who cares

1k v 6k

bozzy_s
24/4/2007
15:37
Thanks for the update moneymad, know nothing about this, just a 75% drop is bound to bring a DCB soon, but it looks like this one has been overdone anyway as they have other pipeline products.

The big cheese from Pfizer would not join them on the back of a single drug?


Reckon we may see 60/70 tomorrow.


P

patricktrfc
24/4/2007
15:34
its all over the shop - quidzinn - what d o you think about its other products?

Dont you think this sell off has been overdone?

money mad
24/4/2007
15:29
Bid/offer both @48p but no auction ???

Q

quidzinn
24/4/2007
15:29
LONDON (AFX) - Amarin Corporation PLC said that, following an agreement with
Elan Corp, it has acquired a global license to develop and market a new form of
epilepsy treatment using a formulation patented by Elan.
Amarin said it believes the nasal lorazepam formulation, intended to treat
emergency seizures in epilepsy outpatients, could have annual sales of up to 300
mln usd in the US, partly because it would be more convenient to administer than
the sole treatment currently approved for outpatients by the US Food and Drug
Administration, Diazepam rectal gel.

money mad
24/4/2007
15:29
LONDON (AFX) - Amarin Corporation PLC said that, following an agreement with
Elan Corp, it has acquired a global license to develop and market a new form of
epilepsy treatment using a formulation patented by Elan.
Amarin said it believes the nasal lorazepam formulation, intended to treat
emergency seizures in epilepsy outpatients, could have annual sales of up to 300
mln usd in the US, partly because it would be more convenient to administer than
the sole treatment currently approved for outpatients by the US Food and Drug
Administration, Diazepam rectal gel.

money mad
24/4/2007
15:28
We expanded Amarin's development pipeline with the acquisition of global
rights to a novel oral formulation of apomorphine and made significant progress
on its development during the year

money mad
24/4/2007
15:26
this isnt its only product have a read through its history
money mad
24/4/2007
15:21
20p and i might consider it!
danski
24/4/2007
15:20
Will pick some up at 20p - not before!
double6
24/4/2007
15:19
too risky for me. good luck to anyone trying to bottomfish.

if the analysts/press get bearish tomorrow, it could get caned further. if they start talking up the other stuff, then you'll make your money quickly...

danski
24/4/2007
15:15
MMs still messing around with share price - will take a while until the dust settles - always going to be a risky punt though.

Q

quidzinn
24/4/2007
14:56
In at 44, 75%+ down on the day and downside limited to 17p cash in bank. Will be back out at 66, easy 50% within a week or so.

Risky punt, but have made nicely on Imperial Energy so this is a freebie for me.


Best of luck to all


P

patricktrfc
24/4/2007
14:49
this was clearly their headline act - they do mention others in dispatches - but if so much store was placed on just this one drug, then it was a highly speculative venture indeed, even by the standards of the biotech sector.
danski
24/4/2007
14:35
What confidence is there now in other pipeline products? They may as well be drilling for oil

Q

quidzinn
Chat Pages: 9  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock